Last reviewed · How we verify
rPA vaccine containing alhydrogel — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
rPA vaccine containing alhydrogel (rPA vaccine containing alhydrogel) — PharmAthene UK Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| rPA vaccine containing alhydrogel TARGET | rPA vaccine containing alhydrogel | PharmAthene UK Limited | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- rPA vaccine containing alhydrogel CI watch — RSS
- rPA vaccine containing alhydrogel CI watch — Atom
- rPA vaccine containing alhydrogel CI watch — JSON
- rPA vaccine containing alhydrogel alone — RSS
Cite this brief
Drug Landscape (2026). rPA vaccine containing alhydrogel — Competitive Intelligence Brief. https://druglandscape.com/ci/rpa-vaccine-containing-alhydrogel. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab